Ju In Eom
Impact in
- Hematology top 10%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
-
- PI3K/AKT/mTOR signaling in cancer
- Protein Kinase Regulation and GTPase Signaling
- Histone Deacetylase Inhibitors Research
- Cell death mechanisms and regulation
Papers in
-
- PI3K/AKT/mTOR signaling in cancer 2
- Ubiquitin and proteasome pathways 1
- FOXO transcription factor regulation 1
- Oncology 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Yoo Hong Min (10 shared papers)June‐Won Cheong (9 shared papers)Seung‐Tae Lee (4 shared papers)Jin Seok Kim (4 shared papers)Jee Sook Hahn (3 shared papers)Yun Woong Ko (3 shared papers)Ae Jin Choi (1 shared paper)Jin‐Ku Lee (1 shared paper)
- Journals
- Blood (2 papers)British Journal of Haematology (1 paper)Clinical Cancer Research (1 paper)Journal of Pharmacology and Experimental Therapeutics (1 paper)Cancer Letters (1 paper)
- Partner nations
- South KoreaUnited States
In The Last Decade
Ju In Eom
10 papers receiving 480 citations
Peers
Comparison fields: 5 of 55
- Hematology 103
- Molecular Biology 344
- Genetics 44
- Oncology 104
- Cancer Research 53
Countries citing papers authored by Ju In Eom
This map shows the geographic impact of Ju In Eom's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ju In Eom with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ju In Eom more than expected).
Fields of papers citing papers by Ju In Eom
This network shows the impact of papers produced by Ju In Eom. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ju In Eom. The network helps show where Ju In Eom may publish in the future.
Co-authors
The 19 scholars most cited alongside Ju In Eom, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2007 | 165 | |
| 2 | 2004 | 82 | |
| 3 | 2003 | 72 | |
| 4 | Induction of apoptosis by apicidin, a histone deacetylase inhibitor, via the activation of mitochondria-dependent caspase cascades in human Bcr-Abl-positive leukemia cells. | 2003 | 65 |
| 5 | 2010 | 36 | |
| 6 | 2003 | 35 | |
| 7 | 2016 | 18 | |
| 8 | 2010 | 13 | |
| 9 | 2008 | 1 | |
| 10 | 2007 | 1 |
About Ju In Eom
Ju In Eom is a scholar working on Molecular Biology, Oncology, Hematology, Immunology and Cancer Research, having authored 10 papers that have together received 488 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (2 papers), NF-κB Signaling Pathways (2 papers), Sesquiterpenes and Asteraceae Studies (2 papers), Cancer-related Molecular Pathways (2 papers), PI3K/AKT/mTOR signaling in cancer (2 papers), Chronic Myeloid Leukemia Treatments (1 paper), Ubiquitin and proteasome pathways (1 paper) and FOXO transcription factor regulation (1 paper). The work is most often cited by research in Hematology (103 citations), Molecular Biology (344 citations), Genetics (44 citations), Oncology (104 citations) and Cancer Research (53 citations). Ju In Eom has collaborated with scholars based in South Korea and United States. Frequent co-authors include Yoo Hong Min, June‐Won Cheong, Seung‐Tae Lee, Jin Seok Kim, Jee Sook Hahn, Yun Woong Ko, Ae Jin Choi, Jin‐Ku Lee, Woo Ick Yang and Hoyoung Maeng. Their work appears in journals such as Blood, British Journal of Haematology, Clinical Cancer Research, Journal of Pharmacology and Experimental Therapeutics and Cancer Letters.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.